The Cooper Companies, Inc. (BMV:COO)

Market Cap	274.41B -29.8%
Revenue (ttm)	75.96B +5.1%
Net Income	6.96B -4.4%
EPS	34.71 -4.6%
Shares Out	n/a
PE Ratio	39.43
Forward PE	17.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38
Average Volume	338
Open	1,406.50
Previous Close	n/a
Day's Range	1,406.50 - 1,406.50
52-Week Range	1,222.81 - 1,890.00
Beta	1.03
RSI	46.59
Earnings Date	Mar 5, 2026

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 15,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: COO

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Financial numbers in USD